Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Biognosys logo — Transforming life sciences with cutting-edge proteomics tech...

Biognosys

Transforming life sciences with cutting-edge proteomics technology and solutions

Founded 2008 Switzerland Schlieren, Switzerland 90 employees Series G Total: $9.03M Biotechnology, Health Care

General Information

Company Name Biognosys
Founded Year 2008
Location Switzerland Schlieren, Switzerland +3
Employees 90
Industries Biotechnology, Health Care
Funding Stage Series G
Social

Get notified when Biognosys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Biognosys

Biognosys is a Swiss biotechnology startup focused on transforming life sciences with cutting-edge proteomics technology and solutions. Since its establishment in 2008, the company has been revolutionizing disease diagnosis, treatment, and prevention through the decoding of the proteome. Biognosys offers a versatile portfolio of proprietary proteomics services, software, and kits, catering to pharmaceutical and biotechnology researchers as well as proteomics experts. The company's mass spectrometry-based proteomics solutions enable simultaneous quantification of thousands of proteins across thousands of samples, making it a leader in next-generation proteomics. From its global headquarters just outside of Zurich, Biognosys operates one of the largest high-end mass spectrometry laboratories worldwide for Large-Scale Discovery Proteomics contract research. As of the latest available information, Biognosys has received a Series G investment as of 12 August 2019. The company's global presence is evident through its extensive network of collaborators and distributors, with employees based across Switzerland, Europe, and the US, supporting a global customer base of life science researchers across industry and academia.

Taxonomy: Proteomics, Mass Spectrometry, Drug Discovery, Clinical Research, Biomarker Discovery, Protein Analysis, Neuroscience, Oncology, Immunology, Rare Diseases, Chronic Diseases, Contract Research Services

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series G •••••• - 12 Aug 2019
Series C •••••• 1
Investor
12 Jul 2017
Series C •••••• - 13 Jan 2016
Debt Financing •••••• - 12 Jan 2014
Venture Round •••••• - 07 Dec 2012

View All 8 Funding Rounds

Biognosys Alternatives & Competitors

Biognosys vs
IonOpticks
IonOpticks Australia

Advancing proteomics research with the world's best chromatography.

32 employees
Manufacturing, Medical Devices
Compare Biognosys vs IonOpticks
Biognosys vs
PreOmics
PreOmics Germany

SETTING THE STANDARD FOR PROTEIN ANALYSIS

Series B
56 employees
Analytics, Biotechnology
Compare Biognosys vs PreOmics
Biognosys vs
BIOCIUS Life Sciences
BIOCIUS Life Sciences

Engaging in innovative drug discovery research since 2009, operating from Woburn, Massachusetts as a...

Private Equity
11-50 employees
Biotechnology, Health Care
Compare Biognosys vs BIOCIUS Life Sciences

FAQ About Biognosys

Transforming life sciences with cutting-edge proteomics technology and solutions
Biognosys was founded in 2008.
Biognosys is headquartered in Schlieren, Switzerland.
Biognosys operates in the following industries: Biotechnology, Health Care.
Biognosys has approximately 90 employees.
Biognosys has completed 8 funding rounds, raising a total of $9.03M. The latest funding stage is Series G.
Top alternatives and competitors to Biognosys include IonOpticks, PreOmics, BIOCIUS Life Sciences, biocrates life sciences ag, Atlas Antibodies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biognosys and IonOpticks are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biognosys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy